Stress echocardiography offers an alternative to stress nuclear imaging for the evaluation of coronary artery disease. Although the choice of imaging modality often varies depending on patient characteristics, availability and local expertise [1], stress echocardiography offers several advantages [2] to nuclear techniques including (1) versatility to obtain additional diagnostic information, (2) lower cost, (3) no radiation exposure, and (4) convenience because patients do not need to return for late imaging.


Wall Motion Abnormality Mitral Stenosis Stress Echocardiography Dobutamine Stress Dobutamine Stress Echocardiography 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003; 42(5):954–70.PubMedCrossRefGoogle Scholar
  2. 2.
    Gottdiener JS. Overview of stress echocardiography: uses, advantages, and limitations. Curr Probl Cardiol 2003;28(8):485–516.PubMedCrossRefGoogle Scholar
  3. 3.
    Leong-Poi H, Rim SJ, Le DE, Fisher NG, Wei K, Kaul S. Perfusion versus function: the ischemic cascade in demand ischemia: implications of single-vessel versus multivessel stenosis. Circulation 2002;105(8):987–92.PubMedCrossRefGoogle Scholar
  4. 4.
    Grover-McKay M, Matsuzaki M, Ross J, Jr. Dissociation between regional myocardial dysfunction and subendocardial ST segment elevation during and after exercise-induced ischemia in dogs. J Am Coll Cardiol 1987;10(5):1105–12.PubMedCrossRefGoogle Scholar
  5. 5.
    Feigenbaum HA, W; Ryan, Thomas. Feigenbaum’s Echocardiography. 6 ed: Lippincott Williams and Wilkins; 2005.Google Scholar
  6. 6.
    Higgins JP, Higgins JA. Electrocardiographic exercise stress testing: an update beyond the ST segment. Int J Cardiol 2007;116(3):285–99.PubMedCrossRefGoogle Scholar
  7. 7.
    Oh J SJ, Tajik AJ. The Echo Manual Second ed: Lippincott, Williams and Wilkins; 1999.Google Scholar
  8. 8.
    San Roman JA, Vilacosta I, Castillo JA, et al. Selection of the optimal stress test for the diagnosis of coronary artery disease. Heart 1998;80(4):370–6.PubMedGoogle Scholar
  9. 9.
    Gligorova S, Agrusta M. Pacing stress echocardiography. Cardiovasc Ultrasound 2005;3:36.PubMedCrossRefGoogle Scholar
  10. 10.
    Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106(14):1883–92.PubMedCrossRefGoogle Scholar
  11. 11.
    Grunig E, Janssen B, Mereles D, et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000;102(10):1145–50.PubMedGoogle Scholar
  12. 12.
    Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105(4):539–42.PubMedCrossRefGoogle Scholar
  13. 13.
    Moller JE, Hillis GS, Oh JK, Reeder GS, Gersh BJ, Pellikka PA. Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction. Am Heart J 2006;151(2):419–25.PubMedCrossRefGoogle Scholar
  14. 14.
    Yao SS, Shah A, Bangalore S, Chaudhry FA. Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. J Am Soc Echocardiogr 2007;20(4):352–8.PubMedCrossRefGoogle Scholar
  15. 15.
    von Bibra H, Tuchnitz A, Klein A, Schneider-Eicke J, Schomig A, Schwaiger M. Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: a comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol 2000;36(2):444–52.CrossRefGoogle Scholar
  16. 16.
    Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30(6):1451–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50(7):e1–e157.PubMedCrossRefGoogle Scholar
  18. 18.
    Sabia P, Abbott RD, Afrookteh A, Keller MW, Touchstone DA, Kaul S. Importance of two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms. Circulation 1991;84(4):1615–24.PubMedGoogle Scholar
  19. 19.
    Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42(7):1318–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Acampa W, Spinelli L, Petretta M, Salvatore M, Cuocolo A. Comparison of prognostic value of negative dobutamine stress echocardiography versus single-photon emission computed tomography after acute myocardial infarction. Am J Cardiol 2005;96(1):13–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Applegate RJ, Dell’Italia LJ, Crawford MH. Usefulness of two-dimensional echocardiography during low-level exercise testing early after uncomplicated acute myocardial infarction. Am J Cardiol 1987;60(1):10–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997;95(6):1402–10.PubMedGoogle Scholar
  23. 23.
    Greco CA, Salustri A, Seccareccia F, et al. Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise electrocardiography. J Am Coll Cardiol 1997;29(2):261–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Minardi G, Di Segni M, Manzara CC, et al. Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with Q-wave acute myocardial infarction. Am J Cardiol 1997;80(7):847–51.PubMedCrossRefGoogle Scholar
  25. 25.
    Previtali M, Fetiveau R, Lanzarini L, Cavalotti C, Klersy C. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis. J Am Coll Cardiol 1998;32(2):380–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Quintana M, Lindvall K, Ryden L, Brolund F. Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction. Am J Cardiol 1995;76(16):1115–21.PubMedCrossRefGoogle Scholar
  27. 27.
    Ryan T, Armstrong WF, O’Donnell JA, Feigenbaum H. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987;114(6):1305–16.PubMedCrossRefGoogle Scholar
  28. 28.
    Sicari R, Landi P, Picano E, et al. Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. Eur Heart J 2002;23(13):1030–7.Google Scholar
  29. 29.
    Sicari R, Picano E, Landi P, et al. Prognostic value of dobutamine–atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol 1997;29(2):254–60.Google Scholar
  30. 30.
    Picano E, Pingitore A, Sicari R, et al. Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo Persantine International Cooperative (EPIC) Study Group. J Am Coll Cardiol 1995;26(4):908–13.Google Scholar
  31. 31.
    Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993;72(19):124G–30G.PubMedCrossRefGoogle Scholar
  32. 32.
    Orlandini AD, Tuero EI, Diaz R, Vilamajo OA, Paolasso EA. Acute cardiac rupture during dobutamine–atropine echocardiography stress test. J Am Soc Echocardiogr 2000;13(2):152–3.PubMedGoogle Scholar
  33. 33.
    Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999;130(9):719–28.PubMedGoogle Scholar
  34. 34.
    Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130(9):709–18.PubMedGoogle Scholar
  35. 35.
    Wong Y, Rodwell A, Dawkins S, Livesey SA, Simpson IA. Sex differences in investigation results and treatment in subjects referred for investigation of chest pain. Heart 2001;85(2):149–52.PubMedCrossRefGoogle Scholar
  36. 36.
    Sketch MH, Mohiuddin SM, Lynch JD, Zencka AE, Runco V. Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. Am J Cardiol 1975;36(2):169–73.PubMedCrossRefGoogle Scholar
  37. 37.
    Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 1997;30(3):641–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994;89(2):615–22.PubMedGoogle Scholar
  39. 39.
    Tawa CB, Baker WB, Kleiman NS, Trakhtenbroit A, Desir R, Zoghbi WA. Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease. J Am Soc Echocardiogr 1996;9(1):33–43.PubMedCrossRefGoogle Scholar
  40. 40.
    Luotolahti M, Saraste M, Hartiala J. Exercise echocardiography in the diagnosis of coronary artery disease. Ann Med 1996;28(1):73–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Tian J, Zhang G, Wang X, Cui J, Xiao J. Exercise echocardiography: feasibility and value for detection of coronary artery disease. Chin Med J (Engl) 1996;109(5):381–4.Google Scholar
  42. 42.
    Roger VL, Pellikka PA, Bell MR, Chow CW, Bailey KR, Seward JB. Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation 1997;95(2):405–10.Google Scholar
  43. 43.
    Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995;26(1):18–25.PubMedCrossRefGoogle Scholar
  44. 44.
    Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90(3):1168–76.Google Scholar
  45. 45.
    Roger VL, Pellikka PA, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography. Part I. Exercise echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 1995;70(1):5–15.Google Scholar
  46. 46.
    Marangelli V, Iliceto S, Piccinni G, De Martino G, Sorgente L, Rizzon P. Detection of coronary artery disease by digital stress echocardiography: comparison of exercise, transesophageal atrial pacing and dipyridamole echocardiography. J Am Coll Cardiol 1994;24(1):117–24.PubMedCrossRefGoogle Scholar
  47. 47.
    Roger VL, Pellikka PA, Oh JK, Bailey KR, Tajik AJ. Identification of multivessel coronary artery disease by exercise echocardiography. J Am Coll Cardiol 1994;24(1):109–14.PubMedCrossRefGoogle Scholar
  48. 48.
    Bjornstad K, Aakhus S, Hatle L. Comparison of digital dipyridamole stress echocardiography and upright bicycle stress echocardiography for identification of coronary artery stenosis. Cardiology 1995;86(6):514–20.PubMedCrossRefGoogle Scholar
  49. 49.
    Daoud EG, Pitt A, Armstrong WF. Electrocardiographic response during dobutamine stress echocardiography. Am Heart J 1995;129(4):672–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Ho FM, Huang PJ, Liau CS, et al. Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease. Eur Heart J 1995;16(4):570–5.PubMedGoogle Scholar
  51. 51.
    Ostojic M, Picano E, Beleslin B, et al. Dipyridamole-dobutamine echocardiography: a novel test for the detection of milder forms of coronary artery disease. J Am Coll Cardiol 1994;23(5):1115–22.PubMedCrossRefGoogle Scholar
  52. 52.
    Sharp SM, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 1994;24(4):934–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Pingitore A, Picano E, Colosso MQ, et al. The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 1996;27(5):1164–70.PubMedCrossRefGoogle Scholar
  54. 54.
    Schroder K, Voller H, Dingerkus H, et al. Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine–atropine. Am J Cardiol 1996;77(11):909–14.PubMedCrossRefGoogle Scholar
  55. 55.
    Anthopoulos LP, Bonou MS, Kardaras FG, et al. Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 1996;28(1):52–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Bax JJ, Visser FC, van Lingen A, Visser CA, Teule GJ. Myocardial F-18 fluorodeoxyglucose imaging by SPECT. Clin Nucl Med 1995;20(6):486–90.PubMedCrossRefGoogle Scholar
  57. 57.
    Dionisopoulos PN, Collins JD, Smart SC, Knickelbine TA, Sagar KB. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. J Am Soc Echocardiogr 1997;10(8):811–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Elhendy A, van Domburg RT, Sozzi FB, Poldermans D, Bax JJ, Roelandt JR. Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001;85(6):655–61.PubMedCrossRefGoogle Scholar
  59. 59.
    Ho YL, Wu CC, Huang PJ, et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 1998;135(4):655–62.PubMedCrossRefGoogle Scholar
  60. 60.
    Yamagishi H, Akioka K, Hirata K, et al. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999;40(9):1492–8.PubMedGoogle Scholar
  61. 61.
    Prince CR, Stoddard MF, Morris GT, et al. Dobutamine two-dimensional transesophageal echocardiographic stress testing for detection of coronary artery disease. Am Heart J 1994;128(1):36–41.PubMedCrossRefGoogle Scholar
  62. 62.
    Laurienzo JM, Cannon RO, 3rd, Quyyumi AA, Dilsizian V, Panza JA. Improved specificity of transesophageal dobutamine stress echocardiography compared to standard tests for evaluation of coronary artery disease in women presenting with chest pain. Am J Cardiol 1997;80(11):1402–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Afridi I, Quinones MA, Zoghbi WA, Cheirif J. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994;127(6):1510–5.PubMedCrossRefGoogle Scholar
  64. 64.
    Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998;97(15):1474–80.PubMedGoogle Scholar
  65. 65.
    Davar JI, Brull DJ, Bulugahipitiya S, Coghlan JG, Lipkin DP, Evans TR. Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease. Am J Cardiol 1999;83(1):100–2, A8.PubMedCrossRefGoogle Scholar
  66. 66.
    Heupler S, Mehta R, Lobo A, Leung D, Marwick TH. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997;30(2):414–20.PubMedCrossRefGoogle Scholar
  67. 67.
    Kamaran M, Teague SM, Finkelhor RS, Dawson N, Bahler RC. Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease. Am J Cardiol 1995;76(12):887–91.PubMedCrossRefGoogle Scholar
  68. 68.
    Marcovitz PA, Shayna V, Horn RA, Hepner A, Armstrong WF. Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease. Am J Cardiol 1996;78(4):404–8.PubMedCrossRefGoogle Scholar
  69. 69.
    McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 1998;31(1):144–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27(1):132–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Chung G, Krishnamani R, Senior R. Prognostic value of normal stress echocardiogram in patients with suspected coronary artery disease – a British general hospital experience. Int J Cardiol 2004;94(2–3):181–6.PubMedCrossRefGoogle Scholar
  72. 72.
    Gambhir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30(3):359–66.PubMedGoogle Scholar
  73. 73.
    Sawada SG, Ryan T, Conley MJ, Corya BC, Feigenbaum H, Armstrong WF. Prognostic value of a normal exercise echocardiogram. Am Heart J 1990;120(1):49–55.PubMedCrossRefGoogle Scholar
  74. 74.
    McNeill AJ, Fioretti PM, el-Said SM, Salustri A, de Feyter PJ, Roelandt JR. Dobutamine stress echocardiography before and after coronary angioplasty. Am J Cardiol 1992;69(8):740–5.PubMedCrossRefGoogle Scholar
  75. 75.
    Baer FM, Voth E, Deutsch HJ, et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996;28(1):60–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28(3):558–64.Google Scholar
  77. 77.
    Furukawa T, Haque T, Takahashi M, Kinoshita M. An assessment of dobutamine echocardiography and end-diastolic wall thickness for predicting post-revascularization functional recovery in patients with chronic coronary artery disease. Eur Heart J 1997;18(5):798–806.PubMedGoogle Scholar
  78. 78.
    Gerber BL, Ordoubadi FF, Wijns W, et al. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability. Eur Heart J 2001;22(18):1691–701.Google Scholar
  79. 79.
    Iliceto S, Galiuto L, Marchese A, et al. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996;77(7):441–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Nagueh SF, Vaduganathan P, Ali N, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29(5):985–93.PubMedCrossRefGoogle Scholar
  81. 81.
    Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94(11):2712–9.Google Scholar
  82. 82.
    Qureshi U, Nagueh SF, Afridi I, et al. Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation 1997;95(3):626–35.PubMedGoogle Scholar
  83. 83.
    Varga A, Ostojic M, Djordjevic-Dikic A, et al. Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J 1996;17(4):629–34.Google Scholar
  84. 84.
    Ballal RS, Kapadia S, Secknus MA, Rubin D, Arheart K, Marwick TH. Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography. Am Heart J 1999;137(3):469–75.PubMedCrossRefGoogle Scholar
  85. 85.
    Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001;285(14):1865–73.PubMedCrossRefGoogle Scholar
  86. 86.
    Bossone E, Martinez FJ, Whyte RI, Iannettoni MD, Armstrong WF, Bach DS. Dobutamine stress echocardiography for the preoperative evaluation of patients undergoing lung volume reduction surgery. J Thorac Cardiovasc Surg 1999;118(3):542–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Das MK, Pellikka PA, Mahoney DW, et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000;35(6):1647–53.PubMedCrossRefGoogle Scholar
  88. 88.
    Davila-Roman VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB, Perez JE. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993;21(4):957–63.PubMedCrossRefGoogle Scholar
  89. 89.
    Eichelberger JP SK, Black ER, Green RM, Ouriel K. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol 1993;72(7):602–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Labib SB, Goldstein M, Kinnunen PM, Schick EC. Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: importance of resting wall motion abnormalities. J Am Coll Cardiol 2004;44(1):82–7.PubMedCrossRefGoogle Scholar
  91. 91.
    Lalka SG SS, Dalsing MC, Cikrit DF, Sawchuk AP, Kovacs RL, Segar DS, Ryan T, Feigenbaum H. Dobutamine stress echocardiography as a predictor of cardiac events associated with aortic surgery. J Vasc Surg 1992;15(5):831–40.PubMedCrossRefGoogle Scholar
  92. 92.
    Lane RT, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography for assessment of cardiac risk before noncardiac surgery. Am J Cardiol 1991;68(9):976–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Langan EM, 3rd, Youkey JR, Franklin DP, Elmore JR, Costello JM, Nassef LA. Dobutamine stress echocardiography for cardiac risk assessment before aortic surgery. J Vasc Surg 1993;18(6):905–11; discussion 12–3.PubMedCrossRefGoogle Scholar
  94. 94.
    Morgan PB, Panomitros GE, Nelson AC, Smith DF, Solanki DR, Zornow MH. Low utility of dobutamine stress echocardiograms in the preoperative evaluation of patients scheduled for noncardiac surgery. Anesth Analg 2002;95(3):512–6, table of contents.PubMedCrossRefGoogle Scholar
  95. 95.
    Plotkin JS, Benitez RM, Kuo PC, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998;4(4):253–7.PubMedCrossRefGoogle Scholar
  96. 96.
    Shafritz R, Ciocca RG, Gosin JS, Shindler DM, Doshi M, Graham AM. The utility of dobutamine echocardiography in preoperative evaluation for elective aortic surgery. Am J Surg 1997;174(2):121–5.PubMedCrossRefGoogle Scholar
  97. 97.
    Torres MR, Short L, Baglin T, Case C, Gibbs H, Marwick TH. Usefulness of clinical risk markers and ischemic threshold to stratify risk in patients undergoing major noncardiac surgery. Am J Cardiol 2002;90(3):238–42.PubMedCrossRefGoogle Scholar
  98. 98.
    Cheriex EC, Pieters FA, Janssen JH, de Swart H, Palmans-Meulemans A. Value of exercise Doppler-echocardiography in patients with mitral stenosis. Int J Cardiol 1994;45(3):219–26.PubMedCrossRefGoogle Scholar
  99. 99.
    Reis G, Motta MS, Barbosa MM, Esteves WA, Souza SF, Bocchi EA. Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. J Am Coll Cardiol 2004;43(3):393–401.PubMedCrossRefGoogle Scholar
  100. 100.
    Chirio C, Anselmino M, Mangiardi L, et al. Is dobutamine stress echocardiography predictive of middle and late term outcomes in mitral stenosis patients? Minerva Cardioangiol 2007;55(3):317–23.Google Scholar
  101. 101.
    Mazzotta G, Bonow RO, Pace L, Brittain E, Epstein SE. Relation between exertional ischemia and prognosis in mildly symptomatic patients with single or double vessel coronary artery disease and left ventricular dysfunction at rest. J Am Coll Cardiol 1989;13(3):567–73.PubMedCrossRefGoogle Scholar
  102. 102.
    Quere JP, Monin JL, Levy F, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 2006;113(14):1738–44.PubMedCrossRefGoogle Scholar
  103. 103.
    Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003;108(3):319–24.PubMedCrossRefGoogle Scholar
  104. 104.
    Lange RA, Hillis LD. Dobutamine stress echocardiography in patients with low-gradient aortic stenosis. Circulation 2006;113(14):1718–20.PubMedCrossRefGoogle Scholar
  105. 105.
    Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Lynn G. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2007;50(17):1707–322.PubMedCrossRefGoogle Scholar
  106. 106.
    Mayo Clinic Cardiovascular Working Group on Stress Testing. Cardiovascular stress testing: a description of the various types of stress tests and indications for their use. Mayo Clin Proc 1996;71(1):43–52.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Patricia Nguyen
    • 1
  1. 1.Department of CardiologyStanford University School of MedicinePalo AltoUSA

Personalised recommendations